Related Experiment Video
Updated: Jul 11, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
A beta-mannoside-selective pyrrolic tripodal receptor
Cristina Nativi1, Martina Cacciarini, Oscar Francesconi
1Dipartimento di Chimica Organica, Centro Risonanze Magnetiche, Università di Firenze, Sesto Fiorentino, Florence, Italy.
Organic Letters
|October 12, 2007
Summary
Researchers developed a novel synthetic receptor with exceptional affinity and selectivity for beta-mannose, a significant advancement in carbohydrate recognition. This H-bonding receptor demonstrates the highest selectivity for beta-mannose reported to date.
Area of Science:
- Carbohydrate chemistry
- Supramolecular chemistry
- Chemical sensing
Background:
- Mannosides are crucial in biological processes.
- Developing selective synthetic receptors for carbohydrates remains a challenge.
- Hydrogen-bonding interactions are key for molecular recognition.
Purpose of the Study:
- To design and synthesize a novel pyrrolic tripodal receptor.
- To achieve unprecedented affinity and selectivity for mannosides, particularly beta-mannose.
- To explore the potential of acetalic substituents in receptor design.
Main Methods:
- Synthesis of a tripodal receptor featuring strategically located acetalic substituents.
- Characterization of binding properties using Nuclear Magnetic Resonance (NMR) spectroscopy.
- Affinity and selectivity determination via Isothermal Titration Calorimetry (ITC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
- Quantification of binding affinity using the BC50(0) parameter.
Main Results:
- The synthetic receptor exhibited unprecedented affinity for mannosides.
- The receptor demonstrated the highest selectivity for beta-mannose among synthetic H-bonding receptors.
- Binding properties were thoroughly characterized by multiple biophysical techniques.
Conclusions:
- The novel pyrrolic tripodal receptor represents a significant advancement in synthetic carbohydrate recognition.
- The strategic placement of acetalic substituents is effective for enhancing affinity and selectivity.
- This work provides a new platform for the development of advanced mannoside sensors.
Related Concept Videos
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...